Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care

British Medical Journal

Volumn 320, Issue 7226, 2000, Pages 26-30

  Mynors Wallis, Laurence M ^a   Gath, Dennis H ^a   Day, Ann ^a   Baker, Frances ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUVOXAMINE; PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; GENERAL PRACTITIONER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBLEM SOLVING; RANDOMIZED CONTROLLED TRIAL;

EID: 0034018024     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7226.26     Document Type: Article

References (15)

1. 1 Blacker CVR, Clare AW. The prevalence and treatment of depression in general practice. Psychopharmacology 1998;95:S14-7.
2. 2 Priest RG, Vize C, Roberts A, Tylee A. Lay people's attitudes to treatment of depression. BMJ 1996;313:838-59.
3. 3 Catalan J, Gath DH, Bond A, Day A, Hall L. Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med 1991;21:1013-8.
4. 4 Mynors-Wallis LM, Gath DH, Lloyd-Thomas A, Tomlinson D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995;310:441-5.
5. 5 Mynors-Wallis LM, Davies I, Gray A, Gath DH, Barbour F. Randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders by community nurses in primary care. Br J Psychiatry 1997;170:113-9.
6. 6 Gath DH, Mynors-Wallis LM. Problem-solving treatment in primary care. In: Clark DM, Fairburn CG, eds. Science and practice of cognitive behaviour therapy. Oxford: Oxford University Press, 1997.
7. 7 Spitzer RL, Endicott V, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978;36:773-82.
8. 8 Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
9. 9 Fawcett J, Epstein P, Fiester SJ, Ellan I, Autry J. Clinical management. Imipramine/placebo administration manual. Psychopharmacol Bull 1987;23:309-24.
10. 10 Lewis G, Pelosi AJ. Measuring psychiatric disorder in the community. A standardised assessment for use by lay interviewers. Psychol Med 1982;22:465-86.
11. 11 Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1962;4:561-71.
12. 12 Cooper P, Osborn M, Gath DH, Feggetter G. Evaluation of a modified self-report measure of social adjustment. Br J Psychiatry 1982;141:68-75.
13. 13 Frank E, Prien RF, Jarretl RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-5.
14. 14 Depression Guideline Panel. Depression in primary care. Vol 2. Treatment of major depression. Rockville, MD: US Department of Health and Human Services, 1993 (Clinical practice guidelines No 5).
15. 15 Mynors-Wallis LM, Gath DH. Predictors of treatment outcome for major depression in primary care. Psychol Med 1997;27:731-6.